EVOGLIX
EVOGLIX M 500 Tablet is a combination medicine used to manage type 2 diabetes effectively. It contains Evogliptin 5 mg and Metformin Hydrochloride 500 mg (sustained release). Evogliptin helps increase insulin release and control post-meal sugar levels, while Metformin reduces glucose production and improves insulin sensitivity. This dual action helps maintain stable blood sugar levels throughout the day when combined with proper diet and exercise.
Related products
SITPIN D 10/100
SITPIN D 10/100 is a combination therapy used for effective control of type 2 diabetes...
SITPIN 100
SITPIN 100 contains Sitagliptin 100 mg, a DPP-4 inhibitor used to manage blood sugar levels...
LINANTA M 500
LINANTA M 500 combines Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg, offering dual-action support...
GLIPDIP M FORTE
GLIPDIP M FORTE is a combination therapy designed for better control of type 2 diabetes...
DUET ACT 4 FORTE
DUET ACT 4 FORTE Tablet is a combination medicine used for managing type 2 diabetes...
DUET ACT 4
DUET ACT 4 Tablet is a combination medicine used for effective management of type 2...
DAPAGLIDE M 1000
DAPAGLIDE M 1000 Tablet is a combination medicine used for managing type 2 diabetes effectively....
DAPAGLIDE 10
DAPAGLIDE 10 Tablet contains Dapagliflozin 10 mg, an advanced medicine used to manage type 2...
